Research Article
Effects of the Salt-Processing Method on the Pharmacokinetics and Tissue Distribution of Orally Administered Morinda officinalis How. Extract
Figure 3
Mean (±SD, n = 6) plasma concentrations of rubiadin, rubiadin 1-methyl ether, and monotropein after oral administration of M. officinalis without wood (MO) and salt-processed product (SMO) extracts (40 g/kg). (a) Rubiadin, (b) rubiadin 1-methyl ether, and (c) monotropein.
(a) |
(b) |
(c) |